ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Wednesday

ClearPoint Neuro (NASDAQ:CLPT) is projected to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $8.23 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

ClearPoint Neuro Stock Down 2.0 %

CLPT stock opened at $16.38 on Tuesday. ClearPoint Neuro has a twelve month low of $5.11 and a twelve month high of $19.22. The stock has a market cap of $451.76 million, a P/E ratio of -23.74 and a beta of 1.03. The business’s 50-day moving average price is $16.62 and its 200-day moving average price is $13.72.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on CLPT shares. B. Riley lifted their price objective on ClearPoint Neuro from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Tuesday, January 28th. Lake Street Capital boosted their price target on ClearPoint Neuro from $17.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, January 21st.

ClearPoint Neuro Company Profile

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.